People's Health Dispatch: A comeback for people-centered health models?
This fortnight at the People's Health Dispatch
During his first meeting with legal counsel, Dr. Hussam Abu Safiya confirmed what many feared: since his abduction from Kamal Adwan Hospital, he has endured torture and abuse by Israeli occupation forces—mirroring the experiences of thousands of political prisoners.
While Palestinian health workers struggle to provide care amid a fragile ceasefire, President Donald Trump is pushing policies that further restrict healthcare access both in the US and abroad. In his analysis, Dr. B. Ekbal examines the rise of anti-science figures within the new administration.
In Kerala, India, a different story is unfolding. The public health system there has made major advances in expanding access, delivering cancer care, and treating rare diseases—offering a robust alternative to privatized healthcare. This people-first approach echoes past models like the USSR's system, which inspired many Brazilian health workers.
As support for Public Pharma grows, Alan Rossi Silva from the People’s Health Movement stresses the need to bring these ideas into academic discourse, challenging the current profit-driven paradigm.
Featured articles
Dr. Hussam Abu Safiya has been tortured and denied care while in Israeli prison
In his first meeting with a lawyer since December 2024, Dr. Hussam Abu Safiya confirmed fears of torture and medical neglect in Israeli prison
The rise of anti-science health officials in the US
Dr. B. Ekbal explores how Trump’s appointment of anti-science figures to key health positions could shape US healthcare
Kerala’s healthcare revolution: A triumph over corporate greed and inequality
Kerala’s public healthcare system is providing accessible, high-quality treatment while challenging the profit motive of the private sector
When Brazilian health workers discovered Soviet healthcare
During visits to the USSR, Brazilian health workers witnessed a universal healthcare system with modern technology and well-paid staff, sparking public health debates at home
Public Pharma: still a missing debate in mainstream academia
Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution
